TFF
IBRN icon

The Family Firm’s iShares Neuroscience and Healthcare ETF IBRN Stock Holding History

The Family Firm’s Portfolio IBRN Stock Details IBRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-91
Closed -$2.15K – 495
2024
Q2 		$2.15K Buy
+91
New +$2.16K ﹤0.01% 787

Other funds holding IBRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return

The Family Firm's IBRN Position: Q3 2024 in Review

The Family Firm sold out of iShares Neuroscience and Healthcare ETF (IBRN) in Q3 2024, closing a stake of 91 shares — an estimated $2.15K sold.

The Family Firm first reported a position in IBRN in Q2 2024 and held it in 1 quarter. The position peaked at $2.15K in Q2 2024. 5 funds tracked by Wall St. Rank hold IBRN as of Q3 2024.

  • The Family Firm reported no remaining iShares Neuroscience and Healthcare ETF position as of Q3 2024 after selling out during the quarter.
  • The Family Firm sold 91 iShares Neuroscience and Healthcare ETF shares in Q3 2024, an estimated $2.15K.
  • The Family Firm first reported a position in iShares Neuroscience and Healthcare ETF in Q2 2024 and held it in 1 quarter.
  • The Family Firm's iShares Neuroscience and Healthcare ETF position peaked at $2.15K in Q2 2024.
  • 5 funds tracked by Wall St. Rank held iShares Neuroscience and Healthcare ETF as of Q3 2024.

Based on The Family Firm's 13F filing for Q3 2024, filed 17 Oct 2024.